Genprex Inc (GNPX)
2.51
+0.09
(+3.72%)
USD |
NASDAQ |
May 17, 16:00
2.51
0.00 (0.00%)
After-Hours: 20:00
Genprex Enterprise Value: -1.866M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -1.866M |
| May 16, 2024 | -2.114M |
| May 15, 2024 | -1.952M |
| May 14, 2024 | -1.828M |
| May 13, 2024 | -2.172M |
| May 10, 2024 | -2.306M |
| May 09, 2024 | -2.095M |
| May 08, 2024 | -2.286M |
| May 07, 2024 | -2.000M |
| May 06, 2024 | -1.744M |
| May 03, 2024 | -2.076M |
| May 02, 2024 | -2.229M |
| May 01, 2024 | -2.420M |
| April 30, 2024 | -2.401M |
| April 29, 2024 | -2.363M |
| April 26, 2024 | -2.516M |
| April 25, 2024 | -2.688M |
| April 24, 2024 | -2.516M |
| April 23, 2024 | -2.325M |
| April 22, 2024 | -2.605M |
| April 19, 2024 | -2.668M |
| April 18, 2024 | -2.498M |
| April 17, 2024 | -2.516M |
| April 16, 2024 | -2.344M |
| April 15, 2024 | -2.248M |
| Date | Value |
|---|---|
| April 12, 2024 | -1.618M |
| April 11, 2024 | -1.427M |
| April 10, 2024 | -1.236M |
| April 09, 2024 | -0.8727M |
| April 08, 2024 | -1.083M |
| April 05, 2024 | -1.006M |
| April 04, 2024 | -1.026M |
| April 03, 2024 | -0.7963M |
| April 02, 2024 | -1.312M |
| April 01, 2024 | -1.064M |
| March 28, 2024 | -1.045M |
| March 27, 2024 | -1.560M |
| March 26, 2024 | -1.503M |
| March 25, 2024 | -1.006M |
| March 22, 2024 | -0.8918M |
| March 21, 2024 | -0.9682M |
| March 20, 2024 | -1.536M |
| March 19, 2024 | -0.8382M |
| March 18, 2024 | 0.4011M |
| March 15, 2024 | -0.7346M |
| March 14, 2024 | -0.5563M |
| March 13, 2024 | -0.5117M |
| March 12, 2024 | -0.482M |
| March 11, 2024 | 0.2461M |
| March 08, 2024 | -0.4521M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.688M
Minimum
Apr 25 2024
304.61M
Maximum
Feb 08 2021
58.07M
Average
40.06M
Median
Aug 09 2022
Enterprise Value Benchmarks
| Lifecore Biomedical Inc | -- |
| Jaguar Health Inc | 96.09M |
| Aquestive Therapeutics Inc | 216.71M |
| TFF Pharmaceuticals Inc | -0.0366M |
| Calidi Biotherapeutics Inc | 9.003M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.929M |
| Total Expenses (Quarterly) | 5.987M |
| EPS Diluted (Quarterly) | -3.76 |
| Earnings Yield | -884.7% |